Question follow-through · 9121
Respiratory Syncytial Virus: Vaccination
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of age-based eligibility criteria for the respiratory syncytial virus vaccine.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 15 Oct 2024
- Target answer date
- 17 Oct 2024
- Answer
- 21 Oct 2024 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
15 Oct 2024
Question tabled
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of age-based eligibility criteria for the respiratory syncytial virus vaccine.
17 Oct 2024
Target answer date
Date supplied by the official written-questions record.
21 Oct 2024
Answer published
In June 2023, the Joint Committee on Vaccination and Immunisation (JCVI) suggested an initial respiratory syncytial virus (RSV) programme to potentially vaccinate a cohort aged from 75 to 79 years old, and then for those turning 75 years old in subsequent...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.